Design, Rationale, Methodology, and Aims of a Greek Prospective Idiopathic Pulmonary Fibrosis Registry: Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown origin. Despite the fact that the guidelines on the diagnosis and management of the disease were updated in 2015, incorporating novel agents recently introduced in the therapeutic approach of IPF, there is a lack of data on the epidemiology, disease status, and treatment in clinical practice. Contemporary data provided by national registries in IPF provide valuable information to guide clinical management of the disease in the real-world setting, adjusted to the local needs. Objective: Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF) is a Greek observational registry aiming at gaining further knowledge on the characteristics, management, progression, and outcomes of patients with IPF treated under real-world, clinical practice conditions in Greece. Methods: Approximately 300 patients will be enrolled consecutively in seven reference centers, constituting the largest IPF registry ever established in Greece. Conclusion: This registry is expected to provide data on the characteristics of IPF patients in Greece and the entire clinical management during the course of the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Hutchinson, J., Fogarty, A., Hubbard, R., & McKeever, T. (2015) · European Respiratory Journal · doi:10.1183/09031936.00185114 · Cited by 913
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Gribbin, J., Hubbard, R. B., Le Jeune, I., Smith, C. J. P., West, J., & Tata, L. J. (2006) · Thorax · doi:10.1136/thx.2006.062836 · Cited by 576
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
Fernández Pérez, E. R., Daniels, C. E., St. Sauver, J., Hartman, T. E., Bartholmai, B. J., Yi, E. S., Ryu, J. H., & Schroeder, D. R. (2010) · Chest · doi:10.1378/chest.09-1002 · Cited by 509
RAGHU, G., CRAIG JOHNSON, W., LOCKHART, D., & MAGETO, Y. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9805017 · Cited by 468
Richeldi, L., Cottin, V., du Bois, R. M., Selman, M., Kimura, T., Bailes, Z., Schlenker-Herceg, R., Stowasser, S., & Brown, K. K. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.02.001 · Cited by 463
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
Chaudhary, N. I., Roth, G. J., Hilberg, F., Müller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., & Park, J. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00152106 · Cited by 386
Conte, E., Gili, E., Fagone, E., Fruciano, M., Iemmolo, M., & Vancheri, C. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.014 · Cited by 368
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
Behr, J., Kreuter, M., Hoeper, M. M., Wirtz, H., Klotsche, J., Koschel, D., Andreas, S., Claussen, M., Grohé, C., Wilkens, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00217614 · Cited by 247
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Kolb, M., Richeldi, L., Behr, J., Maher, T. M., Tang, W., Stowasser, S., Hallmann, C., & du Bois, R. M. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208710 · Cited by 235
Jo, H. E., Glaspole, I., Grainge, C., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01592-2016 · Cited by 233
Kreuter, M., Swigris, J., Pittrow, D., Geier, S., Klotsche, J., Prasse, A., Wirtz, H., Koschel, D., Andreas, S., Claussen, M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0621-y · Cited by 210
Epidemiology of interstitial lung diseases in Greece
Karakatsani, A., Papakosta, D., Rapti, A., Antoniou, K. M., Dimadi, M., Markopoulou, A., Latsi, P., Polychronopoulos, V., Birba, G., Ch, L., et al. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.03.001 · Cited by 208
Self-citationNathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., du Bois, R. M., Fagan, E. A., Fishman, R. S., Glaspole, I., Glassberg, M. K., Glasscock, K. F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207011 · Cited by 180
Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria
Raghu, G., Wells, A. U., Nicholson, A. G., Richeldi, L., Flaherty, K. R., Le Maulf, F., Stowasser, S., Schlenker-Herceg, R., & Hansell, D. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0402oc · Cited by 180
Hughes, G., Toellner, H., Morris, H., Leonard, C., & Chaudhuri, N. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5090078 · Cited by 166
Cottin, V., & Maher, T. (2015) · European Respiratory Review · doi:10.1183/09059180.00011514 · Cited by 126
Glaspole, I. N., Chapman, S. A., Cooper, W. A., Ellis, S. J., Goh, N. S., Hopkins, P. M., Macansh, S., Mahar, A., Moodley, Y. P., Paul, E., et al. (2017) · Respirology · doi:10.1111/resp.12989 · Cited by 123
The incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based study
Kornum, J. B., Christensen, S., Grijota, M., Pedersen, L. H., Wogelius, P., Beiderbeck, A. B., & Sørensen, H. T. (2008) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-8-24 · Cited by 121
Epidemiology and distribution of interstitial lung diseases in T urkey
Müsellim, B., Okumuş, G., Uzaslan, E., Akgün, M., Çetınkaya, E., Turan, O., Akkoçlu, A., Hazar, A. F., Köktürk, N., Çalışır, H. C., et al. (2013) · The Clinical Respiratory Journal · doi:10.1111/crj.12035 · Cited by 93
Doubková, M., Švancara, J., Svoboda, M., Šterclová, M., Bartoš, V., Plačková, M., Lacina, L., Žurková, M., Binková, I., Bittenglová, R., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12700 · Cited by 87
O'Brien, E. C., Durheim, M. T., Gamerman, V., Garfinkel, S., Anstrom, K. J., Palmer, S. M., & Conoscenti, C. S. (2016) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2015-000108 · Cited by 75
Loveman, E., Copley, V. R., Colquitt, J. L., Scott, D. A., Clegg, A. J., Jones, J., O’Reilly, K. M., Singh, S., Bausewein, C., & Wells, A. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-63 · Cited by 52
Tzouvelekis, A., Ntolios, P., Karampitsakos, Τ., Tzilas, V., Anevlavis, S., Bouros, E., Steiropoulos, P., Koulouris, N. G., Stratakos, G. K., Froudarakis, Μ. E., et al. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.08.011 · Cited by 50
Self-citationFerrara, G., Carlson, L., Palm, A., Einarsson, J., Olivesten, C., Sköld, M., & Pulmonar, F. T. S. I. (2016) · European Clinical Respiratory Journal · doi:10.3402/ecrj.v3.31090 · Cited by 43
Pharmacological management of IPF
Borie, R., Justet, A., Beltramo, G., Manali, E. D., Pradère, P., Spagnolo, P., & Crestani, B. (2016) · Respirology · doi:10.1111/resp.12778 · Cited by 42
Lederer, D. J., Bradford, W. Z., Fagan, E., Glaspole, I., Glassberg, M. K., Glasscock, K., Kardatzke, D. R., King, T. E., LANCASTER, L. H., Nathan, S. D., et al. (2015) · CHEST Journal · doi:10.1378/chest.14-2817 · Cited by 40
Moodley, Y., Goh, N., Glaspole, I., Macansh, S., Walters, E. H., Chapman, S., Hopkins, P., Reynolds, P. N., Zappala, C., Cooper, W., et al. (2014) · Respirology · doi:10.1111/resp.12358 · Cited by 37
Costabel, U., Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Cottin, V., Flaherty, K., Inoue, Y., Kim, D., et al. (2015) · Pneumologie · doi:10.1055/s-0035-1544829 · Cited by 32
Behr, J., Hoeper, M. M., Kreuter, M., Klotsche, J., Wirtz, H., & Pittrow, D. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2013-000010 · Cited by 28
Wilson, J. W., du Bois, R. M., & King, T. E. (2008) · Thorax · doi:10.1136/thx.2004.031062 · Cited by 27
Antó, J. M., & Cullinan, P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.18s320101 · Cited by 16
Pittrow, D., Klotsche, J., Kreuter, M., Hoeper, M. M., Wirtz, H. R. W., Koschel, D., Claussen, M., Andreas, S., Grohé, C., Geier, S., et al. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.2078 · Cited by 10
Cited by
Behr, J., Prasse, A., Wirtz, H., Koschel, D., Pittrow, D., Held, M., Klotsche, J., Andreas, S., Claussen, M., Grohé, C., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02279-2019 · Cited by 198
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods
Wang, B. R., Edwards, R., Freiheit, E., Ma, Y., Burg, C., de Andrade, J. A., LANCASTER, L. H., Lindell, K. O., Nathan, S. D., Raghu, G., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202001-035sd · Cited by 82
for the EMPIRE registry, Tran, T., Šterclová, M., Moğulkoç, N., Lewandowska, K. B., Müller, V., Hájková, M., Kramer, M. R., Jovanović, D., Tekavec-Trkanjec, J., et al. (2020) · Respiratory Research · doi:10.1186/s12931-019-1271-z · Cited by 78
Patient Registries in Idiopathic Pulmonary Fibrosis
Culver, D. A., Behr, J., Belperio, J. A., Corte, T. J., de Andrade, J. A., Flaherty, K. R., Gulati, M., Huie, T. J., LANCASTER, L. H., Roman, J., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0431ci · Cited by 58
Caro, F. M., Buendía-Roldán, I., Noriega, L., Alberti, M. L., Amaral, A. F., Arbo, G., Auteri, S. J., Bermúdez, A., Curbelo, P., Verduzco, M. D. J. D., et al. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.04.007 · Cited by 20
Metadata
- Authors
- Bouros, D., Daniil, Z., Papakosta, D., Antoniou, K. M., Markopoulou, K., Kolilekas, L., Konstantopoulos, G., Papiris, S., & on behalf of the INDULGE IPF Study Group
- Affiliations
- National and Kapodistrian University of Athens (GR)
- University of Thessaly (GR)
- Aristotle University of Thessaloniki (GR)
- University Hospital of Heraklion (GR)
- G. Papanikolaou General Hospital (GR)
- Sotiria General Hospital (GR)
- Venue
- Respiration
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 96
- Issue
- 1
- Pages
- 41-47
- ISSN
- 0025-7931 (ISSN-L)
- 1423-0356
- OpenAlex
- W2791675662
- Cited by
- 7
- References
- 42
- Citations by year
- 2026: 1 · 2022: 1 · 2020: 4 · 2019: 1
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Respiration (publishedVersion)
- PubMed (publishedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- idiopathic pulmonary fibrosis, patient registry, disease progression, clinical outcomes, real-world clinical practice, Greece
- MeSH terms
- Greece, Humans, Prospective Studies, Registries, Research Design, Disease Progression, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.